Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Prostatic Neoplasms 13Breast Neoplasms 13Colorectal Neoplasms 8Obesity 7Ovarian Neoplasms 6Motor Activity 5Malnutrition 5Rectal Neoplasms 4Polycystic Ovary Syndrome 4Pancreatic Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Radiation Injuries 3Overweight 3Multiple Myeloma 3Melanoma 3Lung Neoplasms 3Gastrointestinal Neoplasms 3Colonic Neoplasms 3Weight Loss 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Insulin Resistance 2Head and Neck Neoplasms 2Glioblastoma 2

Interventions

Metformin 30Exercise 8Pioglitazone 7Inositol 6Insulin 4Acupuncture Therapy 4High-Intensity Interval Training 3Ethinyl Estradiol 3salicylsalicylic acid 2drospirenone and ethinyl estradiol combination 2Water 2Tablets 2Sugars 2Resistance Training 2Preoperative Exercise 2Folic Acid 2Diet Therapy 2Cyproterone Acetate 2Caloric Restriction 2Biguanides 2ziprasidone 1maltodextrin 1lime 1licogliflozin 1exendin (9-39) 1drospirenone 1cinnulin PF 1adrenosterone 1Zoledronic Acid 1World Health Organization oral rehydration solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Insulin Resistance × Diet Therapy × Clear all
NCT07380841 2026-02-02

PCOS-COMBO (9)

Islamabad Medical and Dental College

Phase NA Completed
192 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Weight Loss, Metabolic Syndrome

NCT01482286 2022-03-15

PULSE

Pennington Biomedical Research Center

Phase 3 Terminated
32 enrolled 10 charts

Body Weight, Insulin Resistance, Motor Activity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡